Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban

BACKGROUND: In worldwide, the mortality rate of acute myocardial infarction (AMI) raises year by year. Although the applications of percutaneous coronary intervention (PCI) and anticoagulants effectively reduce the mortality of patients with acute coronary syndrome (ACS), but also increase the incid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mil Med Res
Egile Nagusiak: Zhao, Xin, Yang, Xiao-Xu, Ji, Su-Zhen, Wang, Xiao-Zeng, Wang, Li, Gu, Chong-Huai, Ren, Li-Li, Han, Ya-Ling
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847352/
https://ncbi.nlm.nih.gov/pubmed/27123313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40779-016-0081-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak